Prices delayed by at least 15 minutes | Print
Futura Medical PLC (FUM)
ORD 0.2POpen
9.20p
Previous close
9.29p
Trade high
9.38p
Volume
568,208
Year high
45.56p
Year low
8.00p
Dividend yield
–
Market capitalisation
£27.34 mn
P/E ratio
22.66
ISIN
GB0033278473
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 12/06/2025 | 04:35:02 | 9 | 75,818 | 6,823.62 |
| 12/06/2025 | 04:07:09 | 9.168 | 4,500 | 412.56 |
| 12/06/2025 | 02:43:14 | 8.9534 | 100 | 8.95 |
| 12/06/2025 | 01:34:02 | 9.24 | 73 | 6.75 |
| 12/06/2025 | 01:00:00 | 8.934 | 25,000 | 2,233.50 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.